Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Res Int ; 2015: 350764, 2015.
Article in English | MEDLINE | ID: mdl-26583102

ABSTRACT

The aim of this study was to characterize clinical field isolates of Leishmania spp. obtained from patients with American Tegumentary Leishmaniasis (ATL) who live in Goiás state, Brazil. The presumed areas of infection were in Goiás, Tocantins, and Pará states. Three isolates of parasites were identified as L. (Viannia) braziliensis and one as L. (V.) guyanensis. The in vitro growth profiles were found to be similar for all parasites. Nevertheless, in C57BL/6 mice, L. (V.) guyanensis infection was better controlled than L. (V.) braziliensis. Yet in C57BL/6 mice deficient in interferon gamma, L. (V.) guyanensis lesions developed faster than those caused by L. (V.) braziliensis isolates. In BALB/c mice, the development of lesions was similar for isolates from both species; however, on the 11th week of infection, amastigotes could not be observed in macrophages from L. (V.) guyanensis-infected mice. Thus, L. (V.) guyanensis can be circulating in Goiás, a state where autochthonous cases of this species had not yet been reported. Considering the difficulties to differentiate L. (V.) guyanensis from L. (V.) braziliensis at the molecular, morphological, and clinical (human and murine models) levels, the presence of L. (V.) guyanensis infections is possibly underestimated in several regions of Brazil.


Subject(s)
Leishmania braziliensis/pathogenicity , Leishmania guyanensis/pathogenicity , Leishmaniasis, Cutaneous/parasitology , Animals , Brazil , Humans , Leishmania braziliensis/isolation & purification , Leishmania guyanensis/isolation & purification , Leishmaniasis, Cutaneous/pathology , Mice
2.
Exp Parasitol ; 118(4): 624-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18155196

ABSTRACT

The isoprenoid metabolic pathway in protozoa of the Leishmania genus exhibits distinctive characteristics. These parasites, as well as other members of the Trypanosomatidae family, synthesize ergosterol, instead of cholesterol, as the main membrane sterol lipid. Leishmania has been shown to utilize leucine, instead of acetate as the main precursor for sterol biosynthesis. While mammalian dolichols are molecules containing 15-23 isoprene units, Leishmania amazonensis promastigotes synthesize dolichol of 11 and 12 units. In this paper, we show that the intracellular stages of L. amazonensis, amastigotes, synthesize mainly polyprenols of 9 isoprene units, instead of dolichol.


Subject(s)
Leishmania mexicana/metabolism , Terpenes/chemistry , Animals , Butadienes/chemistry , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Dolichols/biosynthesis , Dolichols/chemistry , Hemiterpenes/chemistry , Pentanes/chemistry , Spectrometry, Mass, Electrospray Ionization
3.
Nitric Oxide ; 15(3): 209-16, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16527502

ABSTRACT

Nitric oxide (NO) is considered a key molecule in the defense against intracellular pathogens, particularly Leishmania. The expression of inducible nitric oxide synthase and consequent production of NO by infected macrophages has been shown to correlate with leishmaniasis resistance in the murine model as well as in human patients. Nitric oxide donors have been used successfully in the treatment of cutaneous leishmaniasis in humans, although their mechanisms of action are not fully understood. In the present work, the dose-dependent cytotoxic effects of the NO-donors S-nitroso-N-acetyl-l-cysteine (SNAC) and S-nitrosoglutathione (GSNO) against Leishmania were evaluated. GSNO inhibited the growth of Leishmania major and Leishmania amazonensis with in vitro 50% inhibitory concentrations (IC(50)) of 68.8+/-22.86 and 68.9+/-7.9 micromol L(-1), respectively. The IC(50) for SNAC against L. major and L. amazonensis were, respectively, 54.6+/-8.3 and 181.6+/-12.5 micromol L(-1). The leishmanicidal activity of GSNO, but not of SNAC, was reversed by ascorbic acid (AA) and dithiothreitol (DTT), suggesting that the mechanism of action of GSNO is related to the transnitrosation of parasite proteins. These results demonstrate that SNAC and GSNO have leishmanicidal activity, and are thus potential therapeutic agents against cutaneous leishmaniasis.


Subject(s)
Acetylcysteine/analogs & derivatives , Leishmania major/drug effects , Leishmaniasis, Cutaneous/drug therapy , Nitric Oxide Donors , S-Nitrosoglutathione , Acetylcysteine/pharmacology , Acetylcysteine/therapeutic use , Animals , Cell Survival/drug effects , Humans , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , Nitric Oxide Donors/therapeutic use , S-Nitrosoglutathione/pharmacology , S-Nitrosoglutathione/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...